chr12-110127444-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_014055.4(IFT81):āc.64A>Gā(p.Asn22Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000311 in 1,608,890 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N22T) has been classified as Likely benign.
Frequency
Consequence
NM_014055.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IFT81 | NM_014055.4 | c.64A>G | p.Asn22Asp | missense_variant | 2/19 | ENST00000242591.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IFT81 | ENST00000242591.10 | c.64A>G | p.Asn22Asp | missense_variant | 2/19 | 1 | NM_014055.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152182Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000412 AC: 1AN: 242926Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 131504
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1456590Hom.: 0 Cov.: 30 AF XY: 0.00000276 AC XY: 2AN XY: 724332
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152300Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74460
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2022 | The c.64A>G (p.N22D) alteration is located in exon 2 (coding exon 1) of the IFT81 gene. This alteration results from a A to G substitution at nucleotide position 64, causing the asparagine (N) at amino acid position 22 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 27, 2022 | This sequence change replaces asparagine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 22 of the IFT81 protein (p.Asn22Asp). This variant is present in population databases (rs551749665, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with IFT81-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at